GENB Generate Biomedicines, Inc.
$15.38▲ +16.43%
Healthcare
Other
After hours
$15.50▲ +0.78%
Oct 28, 7:53 PM ET
Volume 3.92M
Avg Volume (10D) 751.3K
Key Metrics & Fundamentals
Market Cap
$1.97B
P/E Ratio
–
Div Yield
0.00%
52W Range
11.00 - 22.67
% vs 50 MA
2.18%
% vs 200 MA
–%
RSI-14
59.9
MACD Histogram
+0.2300
Beta (1Y vs SPY)
1.58
Free Cash Flow
-$58.88M
Gross Rev
$6.31M
Gross Profit
$6.31M
EBITDA
-$63.76M
COGS
–
Operating Exp
$77.93M
Operating Income
-$71.61M
EBIT
-$71.61M
Pretax Income
-$67.20M
Net Income
-$67.26M
EPS (Diluted)
-0.52
Price & Volume History
Loading chart…
Recent News
Anthropic Says Claude Helped Generate 35,000 Drug Designs, Cut Drug Development Workloads
MT Newswires · Oct 28, 2026 5:37 AM ET
Generate Biomedicines to Participate in November Investor Conferences
GlobeNewswire · Oct 22, 2026 7:00 AM ET
Zealand Pharma pens $1.2bn AI obesity drug discovery pact with Generate
Pharmaceutical Technology · Oct 14, 2026 12:17 PM ET
Generate Biomedicines Lands Major AI Drug Partnership to Target Booming Obesity Market
Benzinga · Oct 14, 2026 11:30 AM ET
Generate Biomedicines, Zealand Pharma Report Partnership
MT Newswires · Oct 13, 2026 5:10 PM ET
Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
GlobeNewswire · Oct 13, 2026 4:30 PM ET
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
GlobeNewswire · Oct 13, 2026 4:30 PM ET
Prologue Medicines Appoints Stephen Harrison, Ph.D., as Chief Scientific Officer
PR Newswire · Oct 13, 2026 10:00 AM ET
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
GlobeNewswire · Oct 1, 2026 7:00 AM ET
AI Could Eventually Crack Cancer and Drug Discovery, Says Arm CEO — But This Is What’s Holding It Back
Benzinga · Sep 8, 2026 10:36 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See GENB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.